Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Aceragen Inc ACGN

Aceragen, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the clinical development, and commercialization, of drug candidates for rare disease indications characterized by small, well-defined patient populations with serious unmet medical needs. The Company’s pipeline includes ACG-701 to treat cystic fibrosis (CF) pulmonary exacerbations (PEx) and melioidosis, and... see more

Bullboard (NDAQ:ACGN)

View:
Post by Iseneschalon Aug 09, 2023 12:45pm

ACGN ....well I'll be ....sub 50 pesos on tap

wait for it....that last rally to 68 was all shorts  Cheers !
Post by Iseneschalon Aug 09, 2023 12:39pm

ACGN ...now lets see if all the H.O.D Chasers get

their heads handed back in a hand-basket ; ) Time will tell
Post by Iseneschalon Aug 09, 2023 12:29pm

ACGN .... funny thing is....this will move higher....

because you all invited to become Bagholders !!!
Post by Iseneschalon Aug 09, 2023 12:22pm

ACGN.....IDRA acquired ACGN.....now to vote on....

Delisting....sh price has been one big waterfall....what a f'king joke
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities